Angela Mendaros, APRN
Family · Spartanburg, SCNPI 1528424942
Payments from drug & device makers
What this record shows
This record is dominated by other: $273 of the $444 with a category attached, or 61.5%. Welch Allyn accounts for 61.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $273 and has fallen 62.9% since, to $101 in 2025. That places this record below the midpoint for family clinicians in SC, where the typical reported total is $407.
Across 11 payments — averaging $40.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Welch Allyn$273
- GSK$35
- Lilly USA, LLC$34
- Exact Sciences$29
- Pfizer$20
- Dexcom, Inc.$19
- plus $34 from 2 others
What the payments were for
- Food & beverage$17138%
- Other$27362%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Welch Allyn | 1 | $273 |
| GSK | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Exact Sciences | 2 | $29 |
| Pfizer | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spot Vital Signs Monitor$273
How this compares
$444 in reported general payments places this provider in the 50th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $9,049 |
| Gabapentin | 15 | $711 |
| Atorvastatin Calcium | 50 | $363 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $303 |
| Fluticasone Propionate | 22 | $256 |
| Levothyroxine Sodium | 20 | $184 |
| Famotidine | 14 | $168 |
| Diclofenac Sodium | 13 | $155 |
| Lisinopril | 30 | $149 |
| Omeprazole | 18 | $145 |
| Losartan Potassium | 18 | $131 |
| Amlodipine Besylate | 22 | $106 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $61 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $60 |
| Rosuvastatin Calcium | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other family in Spartanburg
- Ashley McKinneySpartanburg$16K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.